logo

Last Update

This profile was last updated on 8/7/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Nicholas Plotnikoff?

Nicholas P. Plotnikoff

Professor of Pharmacology

University of Illinois Medical Center

HQ Phone:  (312) 996-7000

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

University of Illinois Medical Center

2121 West Taylor Street

Chicago, Illinois,60612

United States

Company Description

The University of Illinois Medical Center provides a higher level of care and individual attention to patients and their families, giving special consideration to their unique medical challenges, emotional needs and cultural sensitivities. Our diverse medical ...more

Background Information

Employment History

Chairman

TNI BioTech , Inc.


Affiliations

Immune Therapeutics Inc

Advisory Board Member


University of Illinois

Emeritus Professor of Pharmacology and Psycho-neuro-immuno-logy, College of Pharmacy and College of Medicine


Education

American Board of Toxicology


Ph.D.

China Medical University


Web References(42 Total References)


Advisory Board - Immune Therapeutics, Inc. Information on LDN and MENK

www.immunetherapeutics.com [cached]

Dr. Nicholas Plotnikoff, Non-Executive Chairman
Dr. Plotnikoff has a Ph.D. in pharmacology, with over 20 years of experience in the pharmaceutical industry, having worked in pharmacology, toxicology, and clinical research. He was a professor of pharmacology at the University of Illinois Medical Center in Chicago and played a pioneering role in investigations of the immunological effects of MENK. Dr. Plotnikoff also successfully managed the project teams that developed the NDAs on Traxene (a Valium-like tranquilizer) and Cylert (a non-amphetamine psychostimulant). In basic research, he was the first to identify the central nervous system effects of hypothalamic-releasing factors (brain hormones), resulting in their clinical development for treatment of depression and Parkinson's disease. Dr. Plotnikoff has co-authored 25 publications with Dr. Andrew Schally, covering basic research in the fields of depression and Parkinson's disease, and held a number of international patents for the use of MENK in HIV/AIDS and cancer. Along with the late Dr. Bernard Bihari (see page xx), Dr. Plotnikoff completed Phase I and early Phase II clinical trials in the U.S. using MENK, and has collaborated with Dr. Joseph Wybran from Belgium on clinical trials for treatment by MENK in patients with HIV/AIDS.


Board of Directors

www.tnibiotech.com [cached]

Dr. Nicholas Plotnikoff, Non-Executive Chairman ?
Dr. Plotnikoff has a Ph.D. in Pharmacology, with over 20 years in the pharmaceutical industry, working in Pharmacology, Toxicology, and Clinical Research. Dr. Plotnikoff was a Professor of Pharmacology at the University of Illinois Medical Center in Chicago. Dr. Plotnikoff played a pioneering role in investigations of the immunological effects of MENK. He also successfully managed the project teams that developed the NDAs on Traxene (Valium-like tranquilizer) and Cylert (non-amphetamine psychostimulant). In basic research he was the first to identify the central nervous system effects of hypothalamic releasing factors (brain hormones), resulting in their clinical development for treatment of depression and Parkinson's disease. Dr. Plotnikoff co-authored 25 publications with Dr. Andrew Schally covering basic research in the field of depression and Parkinson's disease. Dr. Plotnikoff held a number of international patents for the use of MENK in HIV/AIDS and cancer.


www.sec.gov

Dr. Nicholas Plotnikoff
Dr. Nicholas Plotnikoff - Dr. Plotnikoff has served as our non-voting, Non-Executive Chairman of the Board since March 2012. Dr. Plotnikoff has a Ph.D. in Pharmacology and over 20 years' experience in the pharmaceutical industry working in Pharmacology, Toxicology, and Clinical Research. Prior to joining our Board, Dr. Plotnikoff was a Professor of Pharmacology at the University of Illinois Medical Center in Chicago from December 1987 until his retirement in May 2008. Dr. Plotnikoff formed TNI Pharmaceutical, Inc. in 1987, which became a public company in 1991. Dr. Plotnikoff served as its Chief Executive Officer and President for 20 years where he helped develop the immunological effects of MENK. He successfully managed the project teams that developed the new drug applications for Traxene (a Valium-like tranquilizer) and Cylert (a non-amphetamine psychostimulant). Dr. Plotnikoff was responsible for the Phase I and Phase II trials for MENK in HIV/AIDS. In basic research, he was the first to identify the central nervous system effects of hypothalamic releasing factors (brain hormones), resulting in clinical development for treatment of depression and Parkinson's disease. Dr. Plotnikoff has co-authored 25 publications with Dr. Andrew Schally, covering basic research in the field of depression and Parkinson's disease. Dr. Plotnikoff was issued a number of international patents for the use of MENK in HIV/AIDS and cancer, which we acquired in 2012. From 2000 to present, Dr. Shan has worked both in the United States and China on the clinical trials with Dr. Nicholas Plotnikoff involving new immunotherapies for the treatment of cancer.


TNI: About Us

www.tnipharm.com [cached]

Nicholas Peter Plotnikoff, President & Director
With more than 25 years of experience in the healthcare sciences industry, the guiding genius behind TNI Pharmaceuticals, Inc. is Dr. Nicholas Plotnikoff, who is known worldwide as the discoverer of the action of hypothalamic releasing hormones on the central nervous system and also as a pioneer for his work on encephalin and endorphins (produced by the immune system). Dr. Plotnikoff secures 28 patents. Prior to founding TNI, Dr. Plotnikoff directed research for Abbott Labs that developed Tranexene, a valium-like tranquilizer. He has also lead the research, development, and treatment applications for several other drugs including Cylert (a non amphetamine stimulant for hyperactive children) and Depekene (an anti-epileptic agent).


Immune Therapeutics, Inc. Information on LDN and MENK - Providing information for Lodonal, low dose naltrexone and MENK

www.immunetherapeutics.com [cached]

Dr. Nicholas Plotnikoff
NE Chairman


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory